PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Namur Institute for Complex Systems (naXys) and Department of Mathematics, University of Namur, Namur, Belgium.\', \'Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.\', \'Department of Infectious Diseases, Centre Hospitalier Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.\', \'Environmental Health Research Centre, Public Health School, Université Libre de Bruxelles (ULB), Brussels, Belgium.\', \'Department of Clinical Chemistry, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium.\', \'Belgian Federal Agency for Medicines and Health Products, 1060, Brussels, Belgium.\', \'Department of Pharmacy, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.\', \'Belgian Federal Agency for Medicines and Health Products, 1060, Brussels, Belgium. Flora.MusuambaTshinanu@fagg-afmps.be.\', \'Faculty of Pharmaceutical Sciences, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo. Flora.MusuambaTshinanu@fagg-afmps.be.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s13318-020-00648-y
?:hasPublicationType
?:journal
  • European journal of drug metabolism and pharmacokinetics
is ?:pmid of
?:pmid
?:pmid
  • 32968954
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.338
?:rankingScore_hIndex
  • 33
is ?:relation_isRelatedTo_publication of
?:title
  • Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all